HKSE - Delayed Quote HKD

Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)

0.935 +0.005 (+0.54%)

At close: 3:57:49 PM GMT+8

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or Entity	Most Recent Transaction	Date	Shares Owned as of Transaction Date
Li (Kei Ling) Chairman of the Board	Acquisition	May 23, 2025	107,708,000
Yu (Liwei) Chief Executive Officer	Conversion	May 14, 2026	1,284,000